These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

326 related items for PubMed ID: 38317104

  • 1. The effects of short-term, progressive exercise training on disease activity in smouldering multiple myeloma and monoclonal gammopathy of undetermined significance: a single-arm pilot study.
    Emery A, Moore S, Crowe J, Murray J, Peacock O, Thompson D, Betts F, Rapps S, Ross L, Rothschild-Rodriguez D, Arana Echarri A, Davies R, Lewis R, Augustine DX, Whiteway A, Afzal Z, Heaney J, Drayson MT, Turner JE, Campbell JP.
    BMC Cancer; 2024 Feb 05; 24(1):174. PubMed ID: 38317104
    [Abstract] [Full Text] [Related]

  • 2. Prognostic Impact of Serum Heavy/Light Chain Pairs in Patients With Monoclonal Gammopathy of Undetermined Significance and Smoldering Myeloma: Long-Term Results From a Single Institution.
    Magnano L, Fernández de Larrea C, Elena M, Cibeira MT, Tovar N, Aróstegui JI, Pedrosa F, Rosiñol L, Filella X, Yagüe J, Bladé J.
    Clin Lymphoma Myeloma Leuk; 2016 Jun 05; 16(6):e71-7. PubMed ID: 27013181
    [Abstract] [Full Text] [Related]

  • 3. Development of a Multivariable Model to Predict the Need for Bone Marrow Sampling in Persons With Monoclonal Gammopathy of Undetermined Significance : A Cohort Study Nested in a Clinical Trial.
    Eythorsson E, Rognvaldsson S, Thorsteinsdottir S, Einarsson Long T, Reed ER, Sigurdardottir GA, Vidarsson B, Onundarson PT, Agnarsson BA, Sigurdardottir M, Olafsson I, Thorsteinsdottir I, Sveinsdottir SV, Sigurdsson F, Thordardottir AR, Palsson R, Indridason OS, Jonsson A, Gislason GK, Olafsson A, Sigurdsson J, Steingrimsdottir H, Hultcrantz M, Durie BGM, Harding S, Landgren O, Aspelund T, Love TJ, Kristinsson SY.
    Ann Intern Med; 2024 Apr 05; 177(4):449-457. PubMed ID: 38560901
    [Abstract] [Full Text] [Related]

  • 4. Smoldering multiple myeloma current treatment algorithms.
    Rajkumar SV, Kumar S, Lonial S, Mateos MV.
    Blood Cancer J; 2022 Sep 05; 12(9):129. PubMed ID: 36064707
    [Abstract] [Full Text] [Related]

  • 5. Monoclonal gammopathies of unknown significance and smoldering myeloma: Assessment and management of the elderly patients.
    González-Calle V, Mateos MV.
    Eur J Intern Med; 2018 Dec 05; 58():57-63. PubMed ID: 29907380
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Changing paradigms in diagnosis and treatment of monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM).
    Ho M, Patel A, Goh CY, Moscvin M, Zhang L, Bianchi G.
    Leukemia; 2020 Dec 05; 34(12):3111-3125. PubMed ID: 33046818
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Impact of prior diagnosis of monoclonal gammopathy on outcomes in newly diagnosed multiple myeloma.
    Goyal G, Rajkumar SV, Lacy MQ, Gertz MA, Buadi FK, Dispenzieri A, Hwa YL, Fonder AL, Hobbs MA, Hayman SR, Zeldenrust SR, Lust JA, Russell SJ, Leung N, Kapoor P, Go RS, Gonsalves WI, Kourelis TV, Warsame R, Kyle RA, Kumar SK.
    Leukemia; 2019 May 05; 33(5):1273-1277. PubMed ID: 30787429
    [Abstract] [Full Text] [Related]

  • 10. SOHO State of the Art Updates and Next Questions: Diagnosis and Management of Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma.
    Schmidt T, Gahvari Z, Callander NS.
    Clin Lymphoma Myeloma Leuk; 2024 Oct 05; 24(10):653-664. PubMed ID: 38641486
    [Abstract] [Full Text] [Related]

  • 11. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management.
    Kyle RA, Durie BG, Rajkumar SV, Landgren O, Blade J, Merlini G, Kröger N, Einsele H, Vesole DH, Dimopoulos M, San Miguel J, Avet-Loiseau H, Hajek R, Chen WM, Anderson KC, Ludwig H, Sonneveld P, Pavlovsky S, Palumbo A, Richardson PG, Barlogie B, Greipp P, Vescio R, Turesson I, Westin J, Boccadoro M, International Myeloma Working Group.
    Leukemia; 2010 Jun 05; 24(6):1121-7. PubMed ID: 20410922
    [Abstract] [Full Text] [Related]

  • 12. Diagnosis, risk stratification and management of monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    van de Donk NW, Mutis T, Poddighe PJ, Lokhorst HM, Zweegman S.
    Int J Lab Hematol; 2016 May 05; 38 Suppl 1():110-22. PubMed ID: 27161311
    [Abstract] [Full Text] [Related]

  • 13. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM): novel biological insights and development of early treatment strategies.
    Korde N, Kristinsson SY, Landgren O.
    Blood; 2011 May 26; 117(21):5573-81. PubMed ID: 21441462
    [Abstract] [Full Text] [Related]

  • 14. MGUS and Smoldering Multiple Myeloma: Diagnosis and Epidemiology.
    Mateos MV, Landgren O.
    Cancer Treat Res; 2016 May 26; 169():3-12. PubMed ID: 27696254
    [Abstract] [Full Text] [Related]

  • 15. Management of monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM).
    Kyle RA, Rajkumar SV.
    Oncology (Williston Park); 2011 Jun 26; 25(7):578-86. PubMed ID: 21888255
    [Abstract] [Full Text] [Related]

  • 16. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    Kyle RA, San-Miguel JF, Mateos MV, Rajkumar SV.
    Hematol Oncol Clin North Am; 2014 Oct 26; 28(5):775-90. PubMed ID: 25212882
    [Abstract] [Full Text] [Related]

  • 17. [Monoclonal gammopathy of undetermined significance and evolution to myeloma: Experience in 153 patients].
    López Gómez JM, Sacristán Enciso B, Fernández-Cavada Pollo MJ, Bueno García V, Gómez Vera S.
    Semergen; 2021 Oct 26; 47(7):441-447. PubMed ID: 34479794
    [Abstract] [Full Text] [Related]

  • 18. Does my patient with a serum monoclonal spike have multiple myeloma?
    Bianchi G, Ghobrial IM.
    Hematol Oncol Clin North Am; 2012 Apr 26; 26(2):383-93, ix. PubMed ID: 22463833
    [Abstract] [Full Text] [Related]

  • 19. Diagnosis and Management of Monoclonal Gammopathy and Smoldering Multiple Myeloma.
    Schmidt T, Callander N.
    J Natl Compr Canc Netw; 2020 Dec 01; 18(12):1720-1729. PubMed ID: 33347744
    [Abstract] [Full Text] [Related]

  • 20. Risk Stratification of Precursors to Multiple Myeloma in 2020.
    Chudasama R, Barth P.
    R I Med J (2013); 2020 Apr 01; 103(3):46-47. PubMed ID: 32236162
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.